Who has invested in ASLAN Pharmaceuticals?

No investors are named on the public record for ASLAN Pharmaceuticals yet.

ASLAN Pharmaceuticals Funding: $300M Raised, IPO (2018)

ASLAN Pharmaceuticals funding overview

ASLAN Pharmaceuticals is based in Singapore. ASLAN Pharmaceuticals has raised $300M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is an IPO announced in January 2018. The round record for ASLAN Pharmaceuticals runs through 2018; nothing later has been disclosed.

ASLAN Pharmaceuticals at a glance

Total raised: $300M
Latest round: IPO
Latest round date: January 2018
Headquarters: Singapore

Frequently asked about ASLAN Pharmaceuticals funding

How much has ASLAN Pharmaceuticals raised?: ASLAN Pharmaceuticals has raised $300M in total disclosed funding across the rounds on record.
Who has invested in ASLAN Pharmaceuticals?: No investors are named on the public record for ASLAN Pharmaceuticals yet.
What was the latest ASLAN Pharmaceuticals funding round?: The most recent disclosed round is an IPO, announced in January 2018.
Where is ASLAN Pharmaceuticals based?: ASLAN Pharmaceuticals is based in Singapore.
When did ASLAN Pharmaceuticals last raise?: The last disclosed ASLAN Pharmaceuticals round closed in January 2018 at IPO.

We update the ASLAN Pharmaceuticals record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Singapore and their backers are listed below.

ASLAN Pharmaceuticals Funding: $300M Raised, IPO (2018)

ASLAN Pharmaceuticals funding overview

ASLAN Pharmaceuticals at a glance

Frequently asked about ASLAN Pharmaceuticals funding

Companies related to ASLAN Pharmaceuticals (18)

Browse related funding lists (5)